These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5985176)

  • 21. [Content of circulating antikidney complement-fixing autoantibodies in the dynamics of pyelonephritis in children].
    Chebotareva VD; Gaevskaia AV
    Pediatr Akus Ginekol; 1974; (2):17. PubMed ID: 4438005
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical aspects of combined kidney diseases (glomerulonephritis and pyelonephritis)].
    Volgina GV
    Klin Med (Mosk); 1981 Jul; 59(7):63-8. PubMed ID: 7278101
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mechanism of the action of circulating antirenal antibodies in chronic pyelonephritis].
    Aripov UA; Pozdniakova TN; Turakulov BR
    Urol Nefrol (Mosk); 1975; (6):8-10. PubMed ID: 1224431
    [No Abstract]   [Full Text] [Related]  

  • 24. [Circulating immune complexes in pyelo- and glomerulonephritis patients].
    Chebotareva VD; Vagdasarova IV; Maĭdannik VG
    Vrach Delo; 1984 Aug; (8):66-9. PubMed ID: 6506618
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
    Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M
    Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoantibodies in calculous pyelonephritis].
    Mishev P; Stoĭchev K
    Urol Nefrol (Mosk); 1967; 32(4):15-7. PubMed ID: 5612571
    [No Abstract]   [Full Text] [Related]  

  • 27. [The immunology of glomerulonephritis and pyelonephritis].
    Shul'ga IuD; Makhlin NV; Polezhaeva AI; Stepanova MV
    Ter Arkh; 1983; 55(6):26-9. PubMed ID: 6604344
    [No Abstract]   [Full Text] [Related]  

  • 28. [The clinical significance of immunological indices in chronic pyelonephritis].
    Shulutko BI; Kulaeva NN; Ambrozas IV; Shumilkin VR; Anikonova LI
    Ter Arkh; 1993; 65(6):11-3. PubMed ID: 8378837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage].
    Cui Z; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indices of specific and nonspecific immunity in children with glomerulonephritis and pyelonephritis].
    Krasnova KN; Chenchikova EP
    Pediatriia; 1970; 49(2):78-83. PubMed ID: 5527486
    [No Abstract]   [Full Text] [Related]  

  • 32. [Disorders of renal tubular functions in chronic glomerulonephritis and pyelonephritis].
    Ovezov BO
    Urol Nefrol (Mosk); 1968; 33(3):8-13. PubMed ID: 5669805
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some tubular functions in chronic glomerulonephritis and pyelonephritis].
    Ratner MIa; Ovezov BO; Lobanova ED
    Sov Med; 1969 Sep; 32(9):68-73. PubMed ID: 5396892
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis].
    Rebenok AZh; Tikhonov II; Chizh AS
    Ter Arkh; 1999; 71(8):62-7. PubMed ID: 10515041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between immunogenic markers with metabolic processes in chronic pyelonephritis].
    Zhmurov VA; Oskolkov SA; Malishevskiĭ MV; Sazonova EV; Mel'nikov AA
    Urologiia; 2000; (3):9-13. PubMed ID: 11186718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Natural inhibitor of macromolecular antibody activity in children with glomerulonephritis and pyelonephritis].
    Sitnikova VP; Zhuravleva NV; Goriainova AN
    Pediatriia; 1986 Feb; (2):13-5. PubMed ID: 3485787
    [No Abstract]   [Full Text] [Related]  

  • 37. [Addis count in chronic primary glomerulovascular kidney diseases and in graft pyelonephritis].
    Bellin H; Schwarz F
    Dtsch Gesundheitsw; 1969 Nov; 24(46):2167-70. PubMed ID: 5385546
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamics of immunological changes in rabbits with experimental pyelonephritis].
    Shvedov LM; Skosogorenko MG; Ukhal' MI
    Urol Nefrol (Mosk); 1974; 0(5):10-3. PubMed ID: 4607553
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis.
    Pusey CD; Lockwood CM
    Prog Clin Biol Res; 1982; 106():91-104. PubMed ID: 6757955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Light microscopic and immunohistologic studies of IgA glomerulonephritis].
    Nagy J; Brasch H; Deák G; Sámik J; Süle T; Trinn C; Burger T
    Morphol Igazsagugyi Orv Sz; 1982 Apr; 22(2):99-108. PubMed ID: 6762501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.